Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

This study has been completed.

Study NCT00012467 Information provided by InterMune

First Received: March 9, 2001 Last Updated: May 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2001
Estimated Primary Completion Date:	No date given